2001
DOI: 10.1007/s005200000191
|View full text |Cite
|
Sign up to set email alerts
|

Psychopharmacology in supportive care of cancer: a review for the clinician

Abstract: Besides benzodiazepine, antidepressant and neuroleptic agents, all of which have established roles in supportive care, other psychotropic drugs deserve consideration in selected conditions affecting patients with advanced cancer. This article briefly reviews relevant aspects of miscellaneous psychotropics available for secondline treatment, including nonbenzodiazepine sedative, hypnotic and anxiolytic drugs, anaesthetic agents, stimulants, and analgesic adjuvants acting on the central nervous system. The prope… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2001
2001
2018
2018

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 15 publications
(1 citation statement)
references
References 45 publications
(57 reference statements)
0
1
0
Order By: Relevance
“…In some instances, pharmacological interventions to alleviate symptoms may not be indicated because of the added burden of drug clearance on the liver and kidneys. Patients with cancer may have underlying hepatic and renal impairments that may result in accumulation of the administered chemotherapeutic drugs and psychotropics, and thus elevated plasma drug levels could occur [ 25 , 26 ].…”
Section: Background Literaturementioning
confidence: 99%
“…In some instances, pharmacological interventions to alleviate symptoms may not be indicated because of the added burden of drug clearance on the liver and kidneys. Patients with cancer may have underlying hepatic and renal impairments that may result in accumulation of the administered chemotherapeutic drugs and psychotropics, and thus elevated plasma drug levels could occur [ 25 , 26 ].…”
Section: Background Literaturementioning
confidence: 99%